BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gutiérrez-Fernández M, de la Cuesta F, Tallón A, Cuesta I, Fernández-Fournier M, Laso-García F, Gómez-de Frutos MC, Díez-Tejedor E, Otero-Ortega L. Potential Roles of Extracellular Vesicles as Biomarkers and a Novel Treatment Approach in Multiple Sclerosis. Int J Mol Sci 2021;22:9011. [PMID: 34445717 DOI: 10.3390/ijms22169011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Barizzone N, Leone M, Pizzino A, Kockum I, Martinelli-boneschi F, D’alfonso S. A Scoping Review on Body Fluid Biomarkers for Prognosis and Disease Activity in Patients with Multiple Sclerosis. JPM 2022;12:1430. [DOI: 10.3390/jpm12091430] [Reference Citation Analysis]
2 Selmaj KW, Mycko MP, Furlan R, Rejdak K. Fluid phase biomarkers in multiple sclerosis. Curr Opin Neurol 2022;35:286-92. [PMID: 35674070 DOI: 10.1097/WCO.0000000000001058] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 González-moro A, Valencia I, Shamoon L, Sánchez-ferrer CF, Peiró C, de la Cuesta F. NLRP3 Inflammasome in Vascular Disease: A Recurrent Villain to Combat Pharmacologically. Antioxidants 2022;11:269. [DOI: 10.3390/antiox11020269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]